Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
April 12, 2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patients
Maria Libera Ascierto, Maciej Kmieciak, Michael O Idowu, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
December 6, 2011
Evaluation of the effect of ammonia on nicotine pharmacokinetics using rapid arterial sampling
Diana L McKinney, Maria Gogova, Bruce D Davies, et al.
Trials
|
April 13, 2022
Effect of novel training to normalize altered finger force direction post-stroke: study protocol for a double-blind randomized controlled trial
Na Jin Seo, Derek G Kamper, Viswanathan Ramakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Physical Therapy
|
January 29, 2019
TheraBracelet Stimulation During Task-Practice Therapy to Improve Upper Extremity Function After Stroke: A Pilot Randomized Controlled Study
Na J Seo, Michelle L Woodbury, Leonardo Bonilha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo
Adly Yacoub, Clint Mitchell, Andrea Lister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2
Beata Holkova, Jeffrey G Supko, Matthew M Ames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2011
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms
Beata Holkova, E Brent Perkins, Viswanathan Ramakrishnan, et al.
The Lancet. Neurology
|
March 29, 2025
Safety and efficacy of transcranial direct current stimulation in addition to constraint-induced movement therapy for post-stroke motor recovery (TRANSPORT2): a phase 2, multicentre, randomised, sham-controlled triple-blind trial
Gottfried Schlaug, Christy Cassarly, Jody A Feld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2014
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms
Beata Holkova, Maciej Kmieciak, E Brent Perkins, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
April 12, 2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patients
Maria Libera Ascierto, Maciej Kmieciak, Michael O Idowu, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
December 6, 2011
Evaluation of the effect of ammonia on nicotine pharmacokinetics using rapid arterial sampling
Diana L McKinney, Maria Gogova, Bruce D Davies, et al.
Trials
|
April 13, 2022
Effect of novel training to normalize altered finger force direction post-stroke: study protocol for a double-blind randomized controlled trial
Na Jin Seo, Derek G Kamper, Viswanathan Ramakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Physical Therapy
|
January 29, 2019
TheraBracelet Stimulation During Task-Practice Therapy to Improve Upper Extremity Function After Stroke: A Pilot Randomized Controlled Study
Na J Seo, Michelle L Woodbury, Leonardo Bonilha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo
Adly Yacoub, Clint Mitchell, Andrea Lister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2
Beata Holkova, Jeffrey G Supko, Matthew M Ames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2011
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms
Beata Holkova, E Brent Perkins, Viswanathan Ramakrishnan, et al.
The Lancet. Neurology
|
March 29, 2025
Safety and efficacy of transcranial direct current stimulation in addition to constraint-induced movement therapy for post-stroke motor recovery (TRANSPORT2): a phase 2, multicentre, randomised, sham-controlled triple-blind trial
Gottfried Schlaug, Christy Cassarly, Jody A Feld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2014
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms
Beata Holkova, Maciej Kmieciak, E Brent Perkins, et al.
Page
of 13